Clasen, Kerstin
Gani, Cihan
Schuetz, Leon
Clasen, Stephan
Ballin, Nadja
Bonzheim, Irina
Orth, Michael
Ossowski, Stephan
Riess, Olaf
Niyazi, Maximilian
Schroeder, Christopher
Kelemen, Olga
Funding for this research was provided by:
Universitätsklinikum Tübingen
Article History
Received: 21 July 2024
Accepted: 14 October 2024
First Online: 6 November 2024
Declarations
:
: All patients declared their (written) informed consent to participate and this study was approved by the local ethics committee in 2015 (reference number 734/2015BO2). The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.
: All patients declared their consent to publish the data of the study.
: KC, CG and MN report institutional collaborations including financial and non-financial support by Elekta, Philips, Siemens, Dr. Sennewald, PTW Freiburg, Kaiku and Therapanacea. CG reports honoraria and travel support from Elekta outside this work. CS reports institutional grants from Novartis and Illumina as well as research grants from BMS Stiftung Immunonkologie outside the submitted work.